Get to know Christina Radvany

Industry Market Manager, Pharma Americas

 

"My goal is to simplify complexity for customers by connecting them with reliable, high-quality partners that help bring therapies to market faster."

  Christina Radvany

What's your area of expertise and how does it create value for our customers and suppliers? 


My main focus is the API pillar within Brenntag Pharma. Our customers already rely on us for a strong excipient portfolio, so my goal is to position Brenntag as a one stop partner by helping customers source both excipients and APIs that align with their formulations simultaneously. This approach helps simplify and harmonize the procurement process, reducing complexity and time to market.

I bring over 14 years in the pharmaceutical industry, most of that time in API procurement. That experience has helped me build a trusted global network of suppliers and given me a clear understanding of customer needs, informed by my own background in purchasing. As regulatory expectations continue to increase, especially from the FDA, it’s more important than ever to work with suppliers who demonstrate strong quality systems, compliance and regulatory expertise. My role is to make sure we align with the right suppliers and deliver long term value to both customers and suppliers.
 

How do you work with partners to achieve the best results?


I work closely with partners by representing API suppliers that have been thoroughly vetted by our regulatory experts. Ensuring that our suppliers operate under the highest quality and compliance standards is foundational to how we collaborate and deliver value. We serve as an extension of our API suppliers’ sales and technical teams, particularly given that more than 85 percent of API manufacturers are international. Through our global presence, we leverage regional experts who can support audits, provide timely feedback and facilitate effective communication across time zones. Beyond compliance, we prioritize speed, transparency and reliability, recognizing that responsive communication is critical to our partners’ and customers’ success.
 

Can you share a real-life example of how your support helped a customer overcome a challenge or achieve their goals?


A common challenge our customers face is sourcing APIs that are constrained due to global supply chain disruptions or limited manufacturer availability. Leveraging Brenntag’s global expertise and established supplier relationships, we have been able to support customers by identifying and qualifying reputable API sources that they were unable to secure independently. In several cases, this enabled customers to maintain development timelines and avoid delays caused by market shortages. Our ability to navigate these supply constraints and provide reliable alternatives has been critical in helping customers achieve their project goals.
 

What trends or changes should industry professionals pay attention to right now and what opportunities do you see ahead?


The API market is increasingly shifting toward oncology, chronic disease therapies and more complex molecules such as high-potency and specialty APIs, driven by innovation and heightened regulatory expectations. We support suppliers operating in these therapeutic areas while helping customers access high-quality APIs that are often difficult to source due to market scarcity, leveraging global expertise and trusted supplier relationships. My expertise in API procurement and supplier qualification helps customers navigate these challenges by identifying reliable partners, ensuring regulatory readiness and supporting both development and commercialization needs.
 

What motivates you most about working in this field and supporting our customers and suppliers?


What motivates me the most is supporting customers and suppliers in bringing critical therapies to market. Having spent much of my career as a buyer myself, I understand firsthand the importance of working with reliable suppliers and partners who can provide accurate information quickly and consistently. The pharmaceutical landscape is constantly evolving, and it is especially motivating to see new therapies emerge for conditions that were once untreatable, as well as branded products becoming more widely accessible through the development of generics. Helping customers achieve their development and commercialization goals while positioning Brenntag as a trusted partner from start to finish across all required materials continues to drive my passion for this field.
 

If followers remember just one thing from this spotlight, what should it be?


That Brenntag is more than a distributor. We're a trusted partner that combines deep API expertise, regulatory rigor and global supplier relationships to help customers reliably source critical materials and bring therapies to market with confidence.

Do you have a question for our Pharma team?


We invite you to reach out to us soon so we can collaborate and work toward exponential growth together.